Tag: Bite therapy

The term "bite therapy" can refer to two entirely different medical treatments: dental solutions for jaw alignment and teeth grinding, or a specific type of cancer immunotherapy called Bispecific T-cell Engager (BiTE) therapy. Each carries a distinct set of potential side effects, making it crucial to understand which treatment is being discussed.

In May 2024, the U.S. Food and Drug Administration (FDA) granted accelerated approval to the immunotherapy **AMG 757**, now known as tarlatamab, for treating extensive-stage small cell lung cancer (SCLC). This approval marked a significant milestone, as treatment options for SCLC that has relapsed after initial chemotherapy have historically been limited.